(Q45049866)

8 December 2017

Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools (English)

1 reference

8 December 2017

1 reference

8

Jos H Beijnen

1 reference

8 December 2017

3

Alwin D R Huitema

1 reference

8 December 2017

Sanjay U C Sankatsing

1

1 reference

8 December 2017

Patrick G Hoggard

2

1 reference

8 December 2017

Rolf W Sparidans

4

1 reference

8 December 2017

Stephen Kewn

5

1 reference

8 December 2017

Kristel M L Crommentuyn

6

1 reference

8 December 2017

Joep M A Lange

7

1 reference

8 December 2017

David J Back

9

1 reference

8 December 2017

Jan M Prins

10

1 reference

8 December 2017

1 January 2004

1 reference

Clinical Pharmacokinetics

8 December 2017

1 reference

8 December 2017

43

1 reference

8 December 2017

12

1 reference

8 December 2017

823-832

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200443120-00004

8 December 2017

0 references

cites work

Mycophenolate mofetil and its mechanisms of action

1 reference

12 December 2020

Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2',3'-dideoxynucleoside activities against replication of human immunodeficiency virus

1 reference

12 December 2020

Clinical pharmacokinetics of mycophenolate mofetil

1 reference

12 December 2020

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

1 reference

12 December 2020

Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.

1 reference

12 December 2020

Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy

1 reference

12 December 2020

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

1 reference

12 December 2020

Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89

1 reference

12 December 2020

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression

1 reference

12 December 2020

Phosphorylation of carbovir enantiomers by cellular enzymes determines the stereoselectivity of antiviral activity

1 reference

12 December 2020

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

1 reference

12 December 2020

Solid-organ transplantation in HIV-infected patients

1 reference

12 December 2020

Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea

1 reference

12 December 2020

Development of enzymatic assays for quantification of intracellular lamivudine and carbovir triphosphate levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients

1 reference

12 December 2020

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication

1 reference

12 December 2020

Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

12 December 2020

Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil

1 reference

12 December 2020

Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

1 reference

12 December 2020

Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity

1 reference

12 December 2020

Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy.

1 reference

12 December 2020

Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection

1 reference

12 December 2020

Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine

1 reference

12 December 2020

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

12 December 2020

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

12 December 2020

Agranulocytosis and fever seven weeks after starting abacavir

1 reference

12 December 2020

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil

1 reference

12 December 2020

Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS

1 reference

12 December 2020

The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA.

1 reference

12 December 2020

Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir

1 reference

12 December 2020

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

1 reference

12 December 2020

Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians

1 reference

12 December 2020

10.2165/00003088-200443120-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

0 references

1 reference